This protocol describes a rapid and simple method to produce bacterial lysate for cell-free gene expression, using an engineered strain of Escherichia coli and requiring only standard laboratory equipment.
Method Article
* These authors contributed equally
This protocol describes a rapid and simple method to produce bacterial lysate for cell-free gene expression, using an engineered strain of Escherichia coli and requiring only standard laboratory equipment.
Cell-free gene expression offers the power of biology without the complications of a living organism. Although many such gene expression systems exist, most are quite expensive to buy and/or require special equipment and finely honed expertise to produce effectively. This protocol describes a method to produce bacterial cell-free lysate that supports high levels of gene expression, using only standard laboratory equipment and requiring minimal processing. The method uses an Escherichia coli strain producing an endolysin that does not affect growth, but which efficiently lyses a harvested cell pellet following a simple freeze-thaw cycle. The only further processing required is a brief incubation followed by centrifugation to clear the autolysate of cellular debris. Dynamic gene circuits can be achieved through heterologous expression of the ClpX protease in the cells before harvesting. An E. coli strain lacking the lacZ gene can be used for high-sensitivity, cell-free biosensing applications using a colorimetric or fluorescent readout. The entire protocol requires as few as 8-9 hours, with only 1-2 hours of hands-on labor from inoculation to completion. By reducing the cost and time to obtain cell-free lysate, this method should increase the affordability of cell-free gene expression for various applications.
Gene expression in cell-free lysates has several advantages over using live cells1,2,3,4. Lysates can be easily modified biochemically and used in conditions that could be detrimental to or impossible to achieve in live cells. Gene expression circuits do not have to contend or compete with host biological processes, and testing new genetic circuits is as simple as adding DNA. For these reasons, cell-free gene expression has found various applications, from biosensors5,6 to rapidly prototyping synthetic gene circuits7,8 to developing artificial cells9. Most cell-free gene expression utilizes cellular lysates that have been highly processed, generally requiring long and complex protocols, specialized equipment, and/or sensitive steps that can lead to significant variation between users and batches10,11.
This paper describes a simple, efficient method for producing cell-free lysate that requires minimal processing and expertise (Figure 1A)12. The method relies on E. coli cells that are engineered to lyse following a simple freeze-thaw cycle. The cells express an endolysin from phage lambda that degrades the cell wall. As the cells are growing, this endolysin remains in the cytoplasm, sequestered from the cell wall. However, a simple freeze-thaw cycle disrupts the cytoplasmic membrane, releasing the endolysin into the periplasm, where it degrades the cell wall, resulting in rapid cell lysis. The protocol can be completed with only a few hours of hands-on work and requires only a freezer, a centrifuge capable of 30,000 × g (for optimal results; lower speeds can be used with more care not to disturb the pellet), a vortex mixer, and a simple buffer solution. Functional lysate can even be produced by freeze-drying the cells and rehydrating them in situ. However, this method produces lysates with lower activity, presumably due to the remaining cell debris.
The lysates are highly active for cell-free gene expression, and they can be enhanced in various ways depending on the end use. The rate of protein synthesis can be further increased by concentrating the lysate using standard spin concentrators. Linear DNA can be protected from degradation by adding purified GamS protein. Protein degradation, necessary for more complex circuit dynamics such as oscillation, can be achieved by co-expressing a ClpX hexamer in the autolysate-producing strain13. Finally, LacZ-based visual readouts are enabled by using an autolysate strain lacking lacZ. Overall, this method produces highly active cell-free lysate that is suitable for a wide range of applications.
Access restricted. Please log in or start a trial to view this content.
1. Prepare media and buffers.
2. Prepare cells.
3. Prepare the lysate.
4. Cell-free gene expression
NOTE: The autolysate is now ready for any desired end-use. The following is an example standard protocol for cell-free gene expression.
5. Protocol modifications
NOTE: The following modifications of the protocol enable it to serve other applications.
NOTE 1: Autolysate cells are designed to lyse upon a freeze-thaw cycle, so it is particularly important to use cryoprotectant when making frozen stocks. We froze stocks in 24% wt/vol glycerol and stored them at -80 °C.
NOTE 2: Magnesium ions and PEG 8000 are critical for lysate performance. The base 2.5x premix, based on previously published data, contains 6 mM magnesium glutamate and 4.8% wt/vol PEG 8000, which become 2.4 mM and 1.9%, respectively, in the final reaction. The autolysate prepared with the protocol here typically performs best with an additional 5 mM Mg-glutamate and 1.5% PEG 8000 in the final reaction. However, this can be optimized in the range of an additional 0-10 mM Mg glutamate and an additional 0-3% PEG 8000 (compared to the base premix). To prepare the premix with the recommended additional 5 mM Mg-glutamate and 1.5% PEG 8000 (final concentrations), mix 380 µL of premix with 4.75 µL of magnesium glutamate at 1 M and 36.1 µL of PEG 8000 at 40% weight/volume.
Access restricted. Please log in or start a trial to view this content.
Representative results can be observed by using autolysate to express GFP from a constitutively expressing plasmid, here pBEST-OR2-OR1-Pr-UTR1-deGFP-T500, and recording a time course of GFP fluorescence in a plate reader (Figure 1B). A dilution series of plasmid DNA found strong expression even at 1 nM DNA. Compared to a commercially available lysate, the autolysate can produce a greater total yield and achieved a greater maximum production rate, calculated as the time derivative of the GFP ...
Access restricted. Please log in or start a trial to view this content.
The protocol described here yields highly active bacterial lysate for cell-free gene expression. The key is to use cells carrying the plasmid pAD-LyseR, which expresses the lambda phage endolysin cytosolically. These cells are potentiated to lyse themselves upon permeabilization of the inner membrane, allowing the endolysin access to the cell wall, which the method achieves through a simple freeze-thaw cycle. Because the cells effectively lyse themselves, the product is referred to as autolysate. After the cells have lys...
Access restricted. Please log in or start a trial to view this content.
J.H. is a co-founder of GenCirq Inc, which focus on cancer therapeutics. He is on the Board of Directors and has equity in GenCirq.
The authors thank Zachary Sun and Richard Murray (California Institute of Technology) for kindly providing the plasmid P_araBAD-gamS, and Kaeko Kamei (Kyoto Institute of Technology) for kindly providing a high-speed cooling centrifuge. This work was supported by grants from the National Institutes of Health and from the ARO MURI program and was partly supported by the Leading Initiative for Excellent Young Researchers, MEXT, Japan.
Access restricted. Please log in or start a trial to view this content.
| Name | Company | Catalog Number | Comments |
|---|---|---|---|
| 2xYT media | EMD Millipore | 4.85008 | or equivalent |
| 3-PGA | Sigma Aldrich | P8877 | or equivalent |
| Amicon Ultra-15 centrifugal filter unit, 3 kDa cutoff | Millipore Sigma | UFC900308 | optional, can be used to concentrate lysate, select concentrator capacity appropriate for the volume to be concentrated |
| ampicillin | Sigma Aldrich | A0166-5G | or carbenicillin, a more stable variant |
| ATP | Sigma Aldrich | A8937 | or equivalent |
| cAMP | Sigma Aldrich | A9501 | or equivalent |
| CoA | Sigma Aldrich | C4282 | or equivalent |
| CTP | United States Biosciences | 14121 | or equivalent |
| D-glucose (dextrose) | Fisher Scientific | AAA1749603 | or equivalent |
| dithiothreitol (DTT) | Sigma Aldrich | D0632-1G | or equivalent |
| E. coli BL21-Gold (DE3) carrying pAD-LyseR | Addgene | 99244 | |
| E. coli BL21-Gold (DE3) ΔlacZ carrying pAD-LyseR | Addgene | 99245 | |
| Folinic acid | Sigma Aldrich | F7878 | or equivalent |
| GTP | United States Biosciences | 16800 | or equivalent |
| HEPES | Sigma Aldrich | H3375-25G | or equivalent |
| LB media | Fisher Scientific | DF0446075 | or equivalent |
| magnesium glutamate | Sigma Aldrich | 49605-250G | or equivalent |
| NAD | Sigma Aldrich | N6522 | or equivalent |
| potassium glutamate | Sigma Aldrich | G1501-100G | or equivalent |
| potassium hydroxide (KOH) | Sigma Aldrich | 221473-25G | for adjusting pH |
| potassium phosphate dibasic | Fisher Scientific | BP363-500 | or equivalent |
| potassium phosphate monobasic | Fisher Scientific | BP362-500 | or equivalent |
| Spermidine | Sigma Aldrich | 85558 | or equivalent |
| Tris-HCl | Fisher Scientific | 9310500GM | or equivalent |
| tRNA mix | Roche | 10109541001 | or equivalent |
| UTP | United States Biosciences | 23160 | or equivalent |
Access restricted. Please log in or start a trial to view this content.
Request permission to reuse the text or figures of this JoVE article
Request Permission